Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice

European Journal of Nutrition

Volumn 51, Issue 5, 2012, Pages 593-606

  Hu, Qing Hua ^a   Zhang, Xian ^a   Wang, Xing ^a   Jiao, Rui Qing ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Hyperuricemia; Quercetin; Renal dysfunction; Renal organic ion transporters; Uromodulin

Indexed keywords

ALLOPURINOL; CARRIER PROTEIN; CREATININE; FLAVONOID; GLUCOSE TRANSPORTER 9; ORGANIC ANION TRANSPORTER 1; ORGANIC CARNITINE TRANSPORTER 1; ORGANIC CARNITINE TRANSPORTER 2; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; OTERACIL; QUERCETIN; RENAL ORGANIC ION TRANSPORTER; RENAL URATE TRANSPORTER 1; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; GENE EXPRESSION; HYPERURICEMIA; KIDNEY FUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENAL PROTECTION; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ALLOPURINOL; ANIMALS; BLOOD UREA NITROGEN; CARRIER PROTEINS; CREATININE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HYPERURICEMIA; KIDNEY; MALE; MEMBRANE PROTEINS; MICE; OCTAMER TRANSCRIPTION FACTOR-1; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; QUERCETIN; RNA, MESSENGER; URIC ACID; URINARY TRACT PHYSIOLOGICAL PHENOMENA; UROMODULIN;

MUS;

EID: 84864688236     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-011-0243-y     Document Type: Article

References (58)

1. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811-1821
2. Richette P, Bardin T (2010) Gout. Lancet 375:318-328
3. Hosoyamada M, Ichida K, Enomoto A et al (2004) Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 15:261-268
4. Nigam SK, Bush KT, Bhatnagar V (2007) Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 3:443-448
5. Vitart V, Rudan I, Hayward C et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40:437-442
6. Preitner F, Bonny O, Laverrière A et al (2009) Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci USA 106:15501-15506
7. Enomoto A, Kimura H, Chairoungdua A et al (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447-452
8. Grover B, Buckley D, Buckley AR et al (2004) Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes. J Pharmacol Exp Ther 308:949-956
9. Tokuhiro S, Yamada R, Chang X et al (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35:341-348
10. Glube N, Closs E, Langguth P (2007) OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1). Mol Pharm 4:160-168
11. Rizwan AN, Burckhardt G (2007) Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 24:450-470
12. Dahan K, Devuyst O, Smaers M et al (2003) A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 14:2883-2893
13. Hart TC, Gorry MC, Hart PS et al (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39:882-892
14. Kemter E, Rathkolb B, Rozman J et al (2009) Novel missense mutation of uromodulin in mice causes renal dysfunction with alterations in urea handling, energy, and bone metabolism. Am J Physiol Renal Physiol 297:1391-1398
15. Egert S, Bosy-Westphal A, Seiberl J et al (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a highcardiovascular disease risk phenotype: a double-blinded, placebocontrolled cross-over study. Br J Nutr 102:1065-1074
16. Perez-Vizcaino F, Duarte J, Jimenez R et al (2009) Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 61:67-75
17. Zhu JX, Wang Y, Kong LD et al (2004) Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 93:133-140
18. Mo SF, Zhou F, Lv YZ et al (2007) Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol Pharm Bull 30:1551-1556
19. Hu QH, Wang C, Li JM et al (2009) Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 297:1080-1091
20. Singh D, Chander V, Chopra K (2004) The effect of quercetin, a bioflavonoid on ischemia/reperfusion induced renal injury in rats. Arch Med Res 35:484-494
21. Renugadevi J, Prabu SM (2010) Quercetin protects against oxidative stress-related renal dysfunction by cadmium in rats. Exp Toxicol Pathol 62:471-481
22. Graf BA, Ameho C, Dolnikowski GG et al (2006) Rat gastrointestinal tissues metabolize quercetin. J Nutr 136:39-44
23. Bieger J, Cermak R, Blank R et al (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138:1417-1420
24. Hong SS, Seo K, Lim SC et al (2007) Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol Res 56:468-473
25. Ofer M, Wolffram S, Koggel A et al (2005) Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur J Pharm Sci 25:263-271
26. Taur JS, Rodriguez-Proteau R (2008) Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models. Xenobiotica 38:1536-1550
27. Bibert S, Hess SK, Firsov D et al (2009) Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol 297:612-619
28. Hu QH, Jiao RQ, Wang X et al (2010) Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice. J Ethnopharmacol 128:685-692
29. Nickel T, Hanssen H, Sisic Z et al (2011) Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur J Nutr 50:163-172
30. Edwards RL, Lyon T, Litwin SE et al (2007) Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137:2405-2411
31. Kalogeromitros D, Makris M, Chliva C et al (2008) A quercetin containing supplement reduces niacin-induced flush in humans. Int J Immunopathol Pharmacol 21:509-514
32. Chen Q (1994) Chinese medicine pharmacology research technology. The people's medical publishing house, Beijing
33. Abdel-Raheem IT, Abdel-Ghany AA, Mohamed GA (2009) Protective effect of quercetin against gentamicin-induced nephrotoxicity in rats. Biol Pharm Bull 32:61-67
34. Perez-Ruiz F, Calabozo M, Erauskin GG et al (2002) Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum 47:610-613
35. Okamoto T (2005) Safety of quercetin for clinical application (review). Int J Mol Med 16:275-278
36. Harwood M, Danielewska-Nikiel B, Borzelleca JF et al (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45:2179-2205
37. Katske F, Shoskes DA, Sender M et al (2001) Treatment of interstitial cystitis with a quercetin supplement. Tech Urol 7:44-46
38. Wong CC, Botting NP, Orfila C et al (2011) Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol 81:942-949
39. Bleyer AJ, Hart TC, Willingham MC et al (2005) Clinico-pathologic findings in medullary cystic kidney disease type 2. Pediatr Nephrol 20:824-827
40. Cappuccio FP, Strazzullo P, Farinaro E et al (1993) Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 270:354-359
41. Cappuccio FP, Iacone R, Strazzullo P (1991) Serum uric acid and proximal sodium excretion: an independent association in man (the Olivetti Study). J Hypertens Suppl 9:280-281
42. Eräranta A, Kurra V, Tahvanainen AM et al (2008) Oxonic acidinduced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency. J Hypertens 26:1661-1668
43. Ruiz MJ, Fernández M, Picó Y et al (2009) Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 57:3180-3186
44. Janssen K, Mensink RP, Cox FJ et al (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 67:255-262
45. Wang XP, Lin L, Bai JQ (2009) Detection of quercetin concentrations in propolis from different manufacturing locations by HPLC. Acta Yunnan Collage Tradit Chin 3:30-32 (in Chinese)
46. Boyer J, Liu RH (2004) Apple phytochemicals and their health benefits. Nutr J 3:5
47. Jung JY, Lim Y, Moon MS et al (2011) Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats. Nutr Metab (Lond) 8:18
48. Lee KW, Kang NJ, Heo YS et al (2008) Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68:946-955
49. Nair MP, Mahajan S, Reynolds JL et al (2006) The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol 13:319-328
50. Kobori M, Masumoto S, Akimoto Y et al (2011) Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 55:530-540
51. de Boer VC, van Schothorst EM, Dihal AA et al (2006) Chronic quercetin exposure affects fatty acid catabolism in rat lung. Cell Mol Life Sci 63:2847-2858
52. Morales AI, Vicente-Sánchez C, Jerkic M et al (2006) Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats. Toxicol Appl Pharmacol 210:128-135
53. Shoskes DA (1998) Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 66:147-152
54. Erlund I, Freese R, Marniemi J et al (2006) Bioavailability of quercetin from berries and the diet. Nutr Cancer 54:13-17
55. Femia AP, Caderni G, Ianni M et al (2003) Effect of diets fortified with tomatoes or onions with variable quercetin-glycoside content on azoxymethane-induced aberrant crypt foci in the colon of rats. Eur J Nutr 42:346-352
56. Ahmad NS, Farman M, Najmi MH et al (2008) Pharmacological basis for use of Pistacia integerrima leaves in hyperuricemia and gout. J Ethnopharmacol 117:478-482
57. Mulholland PJ, Ferry DR, Anderson D et al (2001) Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann Oncol 12:245-248
58. Panda S, Kar A (2007) Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. Biofactors 31:201-210